Integral Diagnostics Ltd
ASX:IDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (16.7), the stock would be worth AU$2.31 (1% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16.6 | AU$2.3 |
0%
|
| 3-Year Average | 16.7 | AU$2.31 |
+1%
|
| 5-Year Average | 17.7 | AU$2.45 |
+6%
|
| Industry Average | 17.4 | AU$2.41 |
+5%
|
| Country Average | 14.1 | AU$1.95 |
-15%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Integral Diagnostics Ltd
ASX:IDX
|
856.4m AUD | 16.6 | 60.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 13.9 | 55 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69B EUR | 10.6 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.7B EUR | 13.1 | 19.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD | 16.2 | 25.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 14 | 21.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 6.6 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD | -67.2 | -28.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 10.3 | 13.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 9.3 |
| Median | 14.1 |
| 70th Percentile | 24.1 |
| Max | 9 251.5 |
Other Multiples
Integral Diagnostics Ltd
Glance View
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.
